Market Cap 344.91B
Revenue (ttm) 42.11B
Net Income (ttm) 14.64B
EPS (ttm) N/A
PE Ratio 23.45
Forward PE 19.80
Profit Margin 34.78%
Debt to Equity Ratio 0.72
Volume 8,895,500
Avg Vol 8,641,406
Day's Range N/A - N/A
Shares Out 4.49B
Stochastic %K 35%
Beta 0.42
Analysts Strong Sell
Price Target $115.58

Latest News on NVO

Novo Nordisk's $2 billion obesity deal

Mar 24, 2025, 11:23 AM EDT - 1 day ago

Novo Nordisk's $2 billion obesity deal

LLY


Novo Nordisk: Stock Plunges, But It May Be Time To Load Up

Mar 14, 2025, 9:00 AM EDT - 11 days ago

Novo Nordisk: Stock Plunges, But It May Be Time To Load Up


Final Trade: AAPL, NVO, ADBE, FCX

Mar 12, 2025, 6:22 PM EDT - 13 days ago

Final Trade: AAPL, NVO, ADBE, FCX

AAPL ADBE FCX


Novo Nordisk: CagriSema Disappoints Again

Mar 10, 2025, 12:52 PM EDT - 15 days ago

Novo Nordisk: CagriSema Disappoints Again


Novo Nordisk shares fall on weight-loss drug trial

Mar 10, 2025, 11:16 AM EDT - 15 days ago

Novo Nordisk shares fall on weight-loss drug trial


Final Trade: GOOGL, NVO, GDX, MP

Mar 7, 2025, 6:19 PM EST - 18 days ago

Final Trade: GOOGL, NVO, GDX, MP

GDX GOOG GOOGL MP